Case Report: KIF5B-ALK–rearranged renal cell carcinoma - Top-Institutions - MDSpire

Case Report: KIF5B-ALK–rearranged renal cell carcinoma

  • By

  • Jiaxi Yao

  • Zhifei Xie

  • Guangyao Shi

  • Ming Tan

  • Zhuo Liu

  • Min Lu

  • Hongxian Zhang

  • June 15, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology

  • #2

    Peking University Third Hospital
    Peking University Third Hospital

    Beijing, Beijing

    Key Differentiators

    • Oncology

  • #3

    Japanese Pediatric Leukemia/Lymphoma Study Group
    Japanese Pediatric Leukemia/Lymphoma Study Group

    Tokyo, Tokyo

    Key Differentiators

    • Pediatric Oncology

  • #4

    Children's Oncology Group
    Children's Oncology Group

    Pediatric Oncology, N/A

    Key Differentiators

    • Pediatric Oncology

  • #5

    Vanderbilt University Medical Center
    Vanderbilt University Medical Center

    Nashville, TN

    Key Differentiators

    • Oncology

Original Source(s)

Case Report: KIF5B-ALK–rearranged renal cell carcinoma

  • by Jiaxi Yao, Zhifei Xie, Guangyao Shi, Ming Tan, Zhuo Liu, Min Lu, Hongxian Zhang

  • June 15, 2026

Related Content

Early detection of multiple cancers: the era of methylation-based liquid biopsy

A deep learning-based radiomic nomogram derived from visceral fat for early prediction of gastrointestinal stromal tumor risk grade

Malignant transformation of uterine serosal endometriosis to clear cell carcinoma in a postmenopausal patient: a rare case report